LENZ Therapeutics CEO Eef Schimmelpennink speaks with RApport about seeking out a new challenge and helping 120 million Americans ditch their reading glasses.
LENZ Therapeutics was recently featured in MSA Partners article "Developing a Treatment for Presbyopia" in Japan
Building a Best-in-Class Company for a Best-in-Class Therapy
LENZ Therapeutics readies pivotal trial of aceclidine to treat presbyopia
LENZ Therapeutics to attend AAO 2021